Relapse prevention treatment for cocaine dependence: group vs. individual format

Addictive Behaviors
J M SchmitzJ Grabowski

Abstract

To investigate the role of treatment modality in relapse prevention treatment, 32 cocaine-dependent subjects were randomly assigned by cohorts to group-based relapse prevention (G-RP) or individually based RP (I-RP). The two RP formats were identical in content, consisting of 12 outpatient treatment sessions over a 2-month period immediately following hospitalization. The proportion of subjects providing cocaine-free urines at the end of RP treatment did not differ between formats; however, G-RP subjects reported using cocaine on significantly fewer days during treatment, and experiencing fewer cocaine-related problems than did I-RP subjects. Follow-up data collected at 12 and 24 weeks' posttreatment revealed no significant differences between RP formats on any cocaine-use outcome measures. Regardless of therapy format. RP treatment was related to statistically significant and sustained improvements in other areas of psychosocial functioning, including addiction severity, coping, and craving for cocaine. The overall findings suggest that the efficacy of relapse prevention training is not limited by therapy format.

References

Apr 1, 1975·Journal of Clinical Psychology·M R O'LearyR A Shea
Mar 1, 1976·The British Journal of Psychiatry : the Journal of Mental Science·L R DerogatisA F Rock
Nov 1, 1992·Archives of General Psychiatry·S S O'MalleyB Rounsaville
Sep 1, 1991·The American Journal of Drug and Alcohol Abuse·K M CarrollF H Gawin
Jan 1, 1990·Addictive Behaviors·J R Ito, D M Donovan
Jan 1, 1989·Journal of Substance Abuse Treatment·B C Wallace
Jan 1, 1988·Addictive Behaviors·J V Wojcik
May 1, 1988·Journal of Abnormal Psychology·M L CooperW H George
Mar 1, 1988·Psychiatry Research·A G BlouinJ H Blouin
Dec 1, 1986·Journal of Consulting and Clinical Psychology·J S BaerE Lichtenstein
Jan 1, 1985·The American Journal of Drug and Alcohol Abuse·J M Brandsma, E M Pattison
Jan 1, 1980·The Journal of Nervous and Mental Disease·A T McLellanC P O'Brien
Jan 1, 1995·Journal of Substance Abuse·J M SchmitzP Mattis
Dec 1, 1994·Journal of Studies on Alcohol. Supplement·M E MattsonR M Kadden
Jan 1, 1994·Journal of Substance Abuse·L M OswaldE L Reilly
Dec 1, 1994·Journal of Consulting and Clinical Psychology·A T McLellanC P O'Brien
Feb 1, 1994·Journal of Consulting and Clinical Psychology·R S StephensE E Simpson
Jan 1, 1994·Behaviour Research and Therapy·D J DrobesS T Tiffany
Jan 1, 1994·The American Journal of Drug and Alcohol Abuse·E A WellsR F Catalano

❮ Previous
Next ❯

Citations

Jul 25, 1997·Drug and Alcohol Dependence·J M SchmitzJ K Breckenridge
Aug 28, 1998·Journal of Substance Abuse·P S Bordnick, J M Schmitz
Feb 16, 2010·Journal of Addictive Diseases·Joy M SchmitzF Gerard Moeller
Oct 30, 2001·Journal of Addictive Diseases·J P MezinskisE Somoza
Jan 24, 2009·Journal of Substance Abuse Treatment·James R McKay
Jan 1, 2008·Drug and Alcohol Dependence·Joy M SchmitzJohn Grabowski
May 8, 2010·Drug and Alcohol Review·Hans O Melberg, Keith Humphreys
Dec 5, 2000·Behaviour Research and Therapy·F C BreslinS Agrawal
Oct 1, 2013·Journal of Substance Abuse Treatment·Janet C BlodgettJohn W Finney
Jul 7, 2007·The American Journal of Drug and Alcohol Abuse·F Gerard MoellerJohn Grabowski
Sep 30, 2016·The Cochrane Database of Systematic Reviews·Silvia MinozziLaura Amato
Jul 11, 2009·Expert Review of Neurotherapeutics·Maurizio PompiliDavid Lester
Nov 24, 2004·Journal of Psychoactive Drugs·Paul J RosenCarl Leukefeld
Feb 21, 2008·Journal of Psychoactive Drugs·M Douglas AnglinDouglas Longshore
Feb 19, 2000·Journal of Psychoactive Drugs·R FiorentineM P Hillhouse
Apr 4, 2015·The Cochrane Database of Systematic Reviews·Werner Paulo KnappMauricio Silva de Lima
Mar 15, 2005·Harvard Review of Psychiatry·Roger D WeissCatherine B Cogley
Oct 18, 2013·The American Journal on Addictions·Elias Dakwar, Frances R Levin
Apr 3, 2018·Journal of Substance Abuse Treatment·Elizabeth E EpsteinMark D Litt
Mar 23, 2019·Journal of Substance Abuse Treatment·Todd A OlmsteadElizabeth E Epstein

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Substance Abuse
P S Bordnick, J M Schmitz
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors
J R McKayRobert Gallop
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Thomas KostenBruce E Wexler
© 2021 Meta ULC. All rights reserved